IBDEI0N5 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23340,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,23340,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,23340,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,23341,0)
 ;;=D06.1^^89^1062^22
 ;;^UTILITY(U,$J,358.3,23341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23341,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,23341,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,23341,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,23342,0)
 ;;=A56.02^^89^1062^23
 ;;^UTILITY(U,$J,358.3,23342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23342,1,3,0)
 ;;=3^Chlamydial Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,23342,1,4,0)
 ;;=4^A56.02
 ;;^UTILITY(U,$J,358.3,23342,2)
 ;;=^5000340
 ;;^UTILITY(U,$J,358.3,23343,0)
 ;;=N81.12^^89^1062^26
 ;;^UTILITY(U,$J,358.3,23343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23343,1,3,0)
 ;;=3^Cystocele,Lateral
 ;;^UTILITY(U,$J,358.3,23343,1,4,0)
 ;;=4^N81.12
 ;;^UTILITY(U,$J,358.3,23343,2)
 ;;=^331535
 ;;^UTILITY(U,$J,358.3,23344,0)
 ;;=N81.11^^89^1062^27
 ;;^UTILITY(U,$J,358.3,23344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23344,1,3,0)
 ;;=3^Cystocele,Midline
 ;;^UTILITY(U,$J,358.3,23344,1,4,0)
 ;;=4^N81.11
 ;;^UTILITY(U,$J,358.3,23344,2)
 ;;=^331534
 ;;^UTILITY(U,$J,358.3,23345,0)
 ;;=N81.10^^89^1062^28
 ;;^UTILITY(U,$J,358.3,23345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23345,1,3,0)
 ;;=3^Cystocele,Unspec
 ;;^UTILITY(U,$J,358.3,23345,1,4,0)
 ;;=4^N81.10
 ;;^UTILITY(U,$J,358.3,23345,2)
 ;;=^5015838
 ;;^UTILITY(U,$J,358.3,23346,0)
 ;;=R87.614^^89^1062^29
 ;;^UTILITY(U,$J,358.3,23346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23346,1,3,0)
 ;;=3^Cytologic Evidence of Malig on Smear of Cervix
 ;;^UTILITY(U,$J,358.3,23346,1,4,0)
 ;;=4^R87.614
 ;;^UTILITY(U,$J,358.3,23346,2)
 ;;=^5019672
 ;;^UTILITY(U,$J,358.3,23347,0)
 ;;=N87.9^^89^1062^36
 ;;^UTILITY(U,$J,358.3,23347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23347,1,3,0)
 ;;=3^Dysplasia of Cervix Uteri,Unspec
 ;;^UTILITY(U,$J,358.3,23347,1,4,0)
 ;;=4^N87.9
 ;;^UTILITY(U,$J,358.3,23347,2)
 ;;=^5015877
 ;;^UTILITY(U,$J,358.3,23348,0)
 ;;=R30.0^^89^1062^37
 ;;^UTILITY(U,$J,358.3,23348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23348,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,23348,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,23348,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,23349,0)
 ;;=N92.1^^89^1062^40
 ;;^UTILITY(U,$J,358.3,23349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23349,1,3,0)
 ;;=3^Excessive/Frequent Menstruation w/ Irregular Cycle
 ;;^UTILITY(U,$J,358.3,23349,1,4,0)
 ;;=4^N92.1
 ;;^UTILITY(U,$J,358.3,23349,2)
 ;;=^5015909
 ;;^UTILITY(U,$J,358.3,23350,0)
 ;;=Z08.^^89^1062^42
 ;;^UTILITY(U,$J,358.3,23350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23350,1,3,0)
 ;;=3^F/U Exam After Malig Neop Treatment
 ;;^UTILITY(U,$J,358.3,23350,1,4,0)
 ;;=4^Z08.
 ;;^UTILITY(U,$J,358.3,23350,2)
 ;;=^5062667
 ;;^UTILITY(U,$J,358.3,23351,0)
 ;;=Z80.3^^89^1062^43
 ;;^UTILITY(U,$J,358.3,23351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23351,1,3,0)
 ;;=3^Family Hx of Breast CA
 ;;^UTILITY(U,$J,358.3,23351,1,4,0)
 ;;=4^Z80.3
 ;;^UTILITY(U,$J,358.3,23351,2)
 ;;=^5063347
 ;;^UTILITY(U,$J,358.3,23352,0)
 ;;=Z80.49^^89^1062^44
 ;;^UTILITY(U,$J,358.3,23352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23352,1,3,0)
 ;;=3^Family Hx of Genital Organ CA
 ;;^UTILITY(U,$J,358.3,23352,1,4,0)
 ;;=4^Z80.49
 ;;^UTILITY(U,$J,358.3,23352,2)
 ;;=^5063351
 ;;^UTILITY(U,$J,358.3,23353,0)
 ;;=Z80.41^^89^1062^45
 ;;^UTILITY(U,$J,358.3,23353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23353,1,3,0)
 ;;=3^Family Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,23353,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,23353,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,23354,0)
 ;;=N73.9^^89^1062^48
 ;;^UTILITY(U,$J,358.3,23354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23354,1,3,0)
 ;;=3^Female Pelvic Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,23354,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,23354,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,23355,0)
 ;;=N60.32^^89^1062^49
 ;;^UTILITY(U,$J,358.3,23355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23355,1,3,0)
 ;;=3^Fibrosclerosis,Left Breast
 ;;^UTILITY(U,$J,358.3,23355,1,4,0)
 ;;=4^N60.32
 ;;^UTILITY(U,$J,358.3,23355,2)
 ;;=^5015780
 ;;^UTILITY(U,$J,358.3,23356,0)
 ;;=N60.31^^89^1062^50
 ;;^UTILITY(U,$J,358.3,23356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23356,1,3,0)
 ;;=3^Fibrosclerosis,Right Breast
 ;;^UTILITY(U,$J,358.3,23356,1,4,0)
 ;;=4^N60.31
 ;;^UTILITY(U,$J,358.3,23356,2)
 ;;=^5015779
 ;;^UTILITY(U,$J,358.3,23357,0)
 ;;=Z01.411^^89^1062^51
 ;;^UTILITY(U,$J,358.3,23357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23357,1,3,0)
 ;;=3^GYN Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,23357,1,4,0)
 ;;=4^Z01.411
 ;;^UTILITY(U,$J,358.3,23357,2)
 ;;=^5062622
 ;;^UTILITY(U,$J,358.3,23358,0)
 ;;=Z01.419^^89^1062^1
 ;;^UTILITY(U,$J,358.3,23358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23358,1,3,0)
 ;;=3
 ;;^UTILITY(U,$J,358.3,23358,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,23358,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,23359,0)
 ;;=Z01.419^^89^1062^52
 ;;^UTILITY(U,$J,358.3,23359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23359,1,3,0)
 ;;=3^GYN Exam w/ Normal Findings
 ;;^UTILITY(U,$J,358.3,23359,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,23359,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,23360,0)
 ;;=R87.613^^89^1062^54
 ;;^UTILITY(U,$J,358.3,23360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23360,1,3,0)
 ;;=3^HGSIL
 ;;^UTILITY(U,$J,358.3,23360,1,4,0)
 ;;=4^R87.613
 ;;^UTILITY(U,$J,358.3,23360,2)
 ;;=^5019671
 ;;^UTILITY(U,$J,358.3,23361,0)
 ;;=R87.612^^89^1062^64
 ;;^UTILITY(U,$J,358.3,23361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23361,1,3,0)
 ;;=3^LGSIL
 ;;^UTILITY(U,$J,358.3,23361,1,4,0)
 ;;=4^R87.612
 ;;^UTILITY(U,$J,358.3,23361,2)
 ;;=^5019670
 ;;^UTILITY(U,$J,358.3,23362,0)
 ;;=R92.1^^89^1062^68
 ;;^UTILITY(U,$J,358.3,23362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23362,1,3,0)
 ;;=3^Mammographic Calcification on Dx Breast Image
 ;;^UTILITY(U,$J,358.3,23362,1,4,0)
 ;;=4^R92.1
 ;;^UTILITY(U,$J,358.3,23362,2)
 ;;=^5019710
 ;;^UTILITY(U,$J,358.3,23363,0)
 ;;=R92.0^^89^1062^69
 ;;^UTILITY(U,$J,358.3,23363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23363,1,3,0)
 ;;=3^Mammographic Microcalcification on Dx Breast Image
 ;;^UTILITY(U,$J,358.3,23363,1,4,0)
 ;;=4^R92.0
 ;;^UTILITY(U,$J,358.3,23363,2)
 ;;=^5019709
 ;;^UTILITY(U,$J,358.3,23364,0)
 ;;=N89.8^^89^1062^74
 ;;^UTILITY(U,$J,358.3,23364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23364,1,3,0)
 ;;=3^Noninflammatory Vaginal Disorder,Oth Spec
 ;;^UTILITY(U,$J,358.3,23364,1,4,0)
 ;;=4^N89.8
 ;;^UTILITY(U,$J,358.3,23364,2)
 ;;=^88111
 ;;^UTILITY(U,$J,358.3,23365,0)
 ;;=R10.2^^89^1062^82
 ;;^UTILITY(U,$J,358.3,23365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23365,1,3,0)
 ;;=3^Pelvic & Perineal Pain
 ;;^UTILITY(U,$J,358.3,23365,1,4,0)
 ;;=4^R10.2
 ;;^UTILITY(U,$J,358.3,23365,2)
 ;;=^5019209
 ;;^UTILITY(U,$J,358.3,23366,0)
 ;;=N94.89^^89^1062^83
 ;;^UTILITY(U,$J,358.3,23366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23366,1,3,0)
 ;;=3^Pelvic Congestion Syndrome
 ;;^UTILITY(U,$J,358.3,23366,1,4,0)
 ;;=4^N94.89
 ;;^UTILITY(U,$J,358.3,23366,2)
 ;;=^5015925
 ;;^UTILITY(U,$J,358.3,23367,0)
 ;;=Z85.3^^89^1062^58
 ;;^UTILITY(U,$J,358.3,23367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23367,1,3,0)
 ;;=3^Hx of Breast CA
 ;;^UTILITY(U,$J,358.3,23367,1,4,0)
 ;;=4^Z85.3
 ;;^UTILITY(U,$J,358.3,23367,2)
 ;;=^5063416
 ;;^UTILITY(U,$J,358.3,23368,0)
 ;;=Z85.43^^89^1062^59
 ;;^UTILITY(U,$J,358.3,23368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23368,1,3,0)
 ;;=3^Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,23368,1,4,0)
 ;;=4^Z85.43
 ;;^UTILITY(U,$J,358.3,23368,2)
 ;;=^5063420
 ;;^UTILITY(U,$J,358.3,23369,0)
 ;;=N94.3^^89^1062^81
